checkAd

     117  0 Kommentare Neuronetics Recognizes Critical Health Professionals During Mental Health Awareness Month

    Leading TMS Company honors clinicians on the front lines who remain dedicated to serving the country’s mental health needs, during May and beyond

    MALVERN, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, is celebrating the professionals delivering critical mental healthcare across the country in honor of Mental Health Awareness Month.

    Prioritizing mental health has never been more imperative than it is today. Since Neuronetics received FDA clearance in 2008 for its NeuroStar Advanced Therapy transcranial magnetic stimulation (TMS) system — a proven, non-drug, non-invasive depression option for adults with Major Depressive Disorder (MDD) — the company has delivered more than 2.5 million treatments and has over 1,000 devices installed in doctors’ offices and hospitals in the United States. NeuroStar practices across the country are going above and beyond to ensure their patients’ mental health needs are met. From expanding services to including telemedicine consultations, virtual care and support groups, to instituting new safety and sanitization protocols and remaining open to guarantee those in the midst of treatment can continue sessions — their services are invaluable, particularly during this time when feelings of uncertainty and chaos threaten to severely exacerbate existing mental health conditions for the many Americans already struggling.

    Depression impacts more than 13.3 million adults in the U.S., but many do not seek treatment or are not helped by antidepressant medications 1,2,3 — resulting in a need for accessible, safe, non-drug treatment options that work. Unlike electroconvulsive therapy (ECT), NeuroStar TMS is a non-invasive treatment that uses magnetic pulses to stimulate areas of the brain that are underactive in depression.4,5 Many NeuroStar practices across the country remain open and continue to offer services for both existing and new patients, and some are seeing even more patients with MDD begin their NeuroStar TMS treatment.

    Seite 1 von 3


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Neuronetics Recognizes Critical Health Professionals During Mental Health Awareness Month Leading TMS Company honors clinicians on the front lines who remain dedicated to serving the country’s mental health needs, during May and beyondMALVERN, Pa., May 07, 2020 (GLOBE NEWSWIRE) - Neuronetics, Inc. (NASDAQ: STIM), a commercial stage …

    Schreibe Deinen Kommentar

    Disclaimer